Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
31
RPHCF Quote, Financials, Valuation and Earnings
Last price:
$15.20
Seasonality move
:
5.18%
Day range:
$15.20 - $15.20
52-week range:
$14.34 - $20.09
Dividend yield:
1.9%
P/E ratio:
15.31x
P/S ratio:
1.56x
P/B ratio:
1.87x
Volume:
--
Avg. volume:
58
1-year change:
-24.34%
Market cap:
$3.4B
Revenue:
$2B
EPS (TTM):
$0.99
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RPHCF
Rohto Pharmaceutical Co., Ltd.
|
-- | -- | -- | -- | -- |
|
ASBRF
Asahi Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
|
CCOJY
Coca-Cola Bottlers Japan Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
KNBWY
Kirin Holdings Co., Ltd.
|
$3.8B | -- | -7.48% | -- | $16.60 |
|
SOOBF
Sapporo Holdings Ltd.
|
-- | -- | -- | -- | -- |
|
TKHIF
Takara Holdings, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RPHCF
Rohto Pharmaceutical Co., Ltd.
|
$15.20 | -- | $3.4B | 15.31x | $0.14 | 1.9% | 1.56x |
|
ASBRF
Asahi Group Holdings Ltd.
|
$10.00 | -- | $15.1B | 13.93x | $0.17 | 3.34% | 0.79x |
|
CCOJY
Coca-Cola Bottlers Japan Holdings, Inc.
|
$11.49 | -- | $3.8B | 51.87x | $0.09 | 0.99% | 0.66x |
|
KNBWY
Kirin Holdings Co., Ltd.
|
$16.29 | $16.60 | $13.1B | 13.38x | $0.24 | 2.84% | 0.81x |
|
SOOBF
Sapporo Holdings Ltd.
|
$48.63 | -- | $19B | 921.02x | $0.57 | 1.18% | 4.47x |
|
TKHIF
Takara Holdings, Inc.
|
$11.20 | -- | $2.2B | 23.68x | $0.20 | 1.69% | 0.84x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RPHCF
Rohto Pharmaceutical Co., Ltd.
|
15.27% | -0.739 | 8.71% | 1.35x |
|
ASBRF
Asahi Group Holdings Ltd.
|
35.14% | 0.069 | 47.57% | 0.31x |
|
CCOJY
Coca-Cola Bottlers Japan Holdings, Inc.
|
26.06% | -0.892 | 24.86% | 0.77x |
|
KNBWY
Kirin Holdings Co., Ltd.
|
43.8% | -0.397 | 45.16% | 0.83x |
|
SOOBF
Sapporo Holdings Ltd.
|
47.57% | -0.203 | 6.68% | 0.54x |
|
TKHIF
Takara Holdings, Inc.
|
20.03% | 0.253 | 15.91% | 1.77x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RPHCF
Rohto Pharmaceutical Co., Ltd.
|
$328.6M | $91.5M | 10.51% | 12.35% | 15.88% | -- |
|
ASBRF
Asahi Group Holdings Ltd.
|
$1.9B | $498.1M | 4.31% | 6.64% | 9.87% | $738M |
|
CCOJY
Coca-Cola Bottlers Japan Holdings, Inc.
|
$605.9M | $7.1M | -9.66% | -12.83% | 0.52% | $123.8M |
|
KNBWY
Kirin Holdings Co., Ltd.
|
$2.1B | $527.3M | 7.28% | 12.18% | 12% | $358.6M |
|
SOOBF
Sapporo Holdings Ltd.
|
$268.9M | $32.1M | 3.66% | 7.73% | 3.98% | $63.8M |
|
TKHIF
Takara Holdings, Inc.
|
$211.6M | $31.4M | 3.23% | 3.95% | 4.62% | -- |
Rohto Pharmaceutical Co., Ltd. vs. Competitors
-
Which has Higher Returns RPHCF or ASBRF?
Asahi Group Holdings Ltd. has a net margin of 11.9% compared to Rohto Pharmaceutical Co., Ltd.'s net margin of 5.16%. Rohto Pharmaceutical Co., Ltd.'s return on equity of 12.35% beat Asahi Group Holdings Ltd.'s return on equity of 6.64%.
Company Gross Margin Earnings Per Share Invested Capital RPHCFRohto Pharmaceutical Co., Ltd.57% $0.29 $2.3B ASBRFAsahi Group Holdings Ltd.38.45% $0.17 $28.5B -
What do Analysts Say About RPHCF or ASBRF?
Rohto Pharmaceutical Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Asahi Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Rohto Pharmaceutical Co., Ltd. has higher upside potential than Asahi Group Holdings Ltd., analysts believe Rohto Pharmaceutical Co., Ltd. is more attractive than Asahi Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RPHCFRohto Pharmaceutical Co., Ltd.0 0 0 ASBRFAsahi Group Holdings Ltd.0 0 0 -
Is RPHCF or ASBRF More Risky?
Rohto Pharmaceutical Co., Ltd. has a beta of -0.205, which suggesting that the stock is 120.51% less volatile than S&P 500. In comparison Asahi Group Holdings Ltd. has a beta of -0.152, suggesting its less volatile than the S&P 500 by 115.236%.
-
Which is a Better Dividend Stock RPHCF or ASBRF?
Rohto Pharmaceutical Co., Ltd. has a quarterly dividend of $0.14 per share corresponding to a yield of 1.9%. Asahi Group Holdings Ltd. offers a yield of 3.34% to investors and pays a quarterly dividend of $0.17 per share. Rohto Pharmaceutical Co., Ltd. pays 26.45% of its earnings as a dividend. Asahi Group Holdings Ltd. pays out 38.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RPHCF or ASBRF?
Rohto Pharmaceutical Co., Ltd. quarterly revenues are $576.5M, which are smaller than Asahi Group Holdings Ltd. quarterly revenues of $5B. Rohto Pharmaceutical Co., Ltd.'s net income of $68.6M is lower than Asahi Group Holdings Ltd.'s net income of $260.2M. Notably, Rohto Pharmaceutical Co., Ltd.'s price-to-earnings ratio is 15.31x while Asahi Group Holdings Ltd.'s PE ratio is 13.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rohto Pharmaceutical Co., Ltd. is 1.56x versus 0.79x for Asahi Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RPHCFRohto Pharmaceutical Co., Ltd.1.56x 15.31x $576.5M $68.6M ASBRFAsahi Group Holdings Ltd.0.79x 13.93x $5B $260.2M
-
Which has Higher Returns RPHCF or CCOJY?
Coca-Cola Bottlers Japan Holdings, Inc. has a net margin of 11.9% compared to Rohto Pharmaceutical Co., Ltd.'s net margin of -0.96%. Rohto Pharmaceutical Co., Ltd.'s return on equity of 12.35% beat Coca-Cola Bottlers Japan Holdings, Inc.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital RPHCFRohto Pharmaceutical Co., Ltd.57% $0.29 $2.3B CCOJYCoca-Cola Bottlers Japan Holdings, Inc.44.39% -$0.04 $3.3B -
What do Analysts Say About RPHCF or CCOJY?
Rohto Pharmaceutical Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Coca-Cola Bottlers Japan Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Rohto Pharmaceutical Co., Ltd. has higher upside potential than Coca-Cola Bottlers Japan Holdings, Inc., analysts believe Rohto Pharmaceutical Co., Ltd. is more attractive than Coca-Cola Bottlers Japan Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RPHCFRohto Pharmaceutical Co., Ltd.0 0 0 CCOJYCoca-Cola Bottlers Japan Holdings, Inc.0 0 0 -
Is RPHCF or CCOJY More Risky?
Rohto Pharmaceutical Co., Ltd. has a beta of -0.205, which suggesting that the stock is 120.51% less volatile than S&P 500. In comparison Coca-Cola Bottlers Japan Holdings, Inc. has a beta of -0.251, suggesting its less volatile than the S&P 500 by 125.122%.
-
Which is a Better Dividend Stock RPHCF or CCOJY?
Rohto Pharmaceutical Co., Ltd. has a quarterly dividend of $0.14 per share corresponding to a yield of 1.9%. Coca-Cola Bottlers Japan Holdings, Inc. offers a yield of 0.99% to investors and pays a quarterly dividend of $0.09 per share. Rohto Pharmaceutical Co., Ltd. pays 26.45% of its earnings as a dividend. Coca-Cola Bottlers Japan Holdings, Inc. pays out 78.95% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RPHCF or CCOJY?
Rohto Pharmaceutical Co., Ltd. quarterly revenues are $576.5M, which are smaller than Coca-Cola Bottlers Japan Holdings, Inc. quarterly revenues of $1.4B. Rohto Pharmaceutical Co., Ltd.'s net income of $68.6M is higher than Coca-Cola Bottlers Japan Holdings, Inc.'s net income of -$13M. Notably, Rohto Pharmaceutical Co., Ltd.'s price-to-earnings ratio is 15.31x while Coca-Cola Bottlers Japan Holdings, Inc.'s PE ratio is 51.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rohto Pharmaceutical Co., Ltd. is 1.56x versus 0.66x for Coca-Cola Bottlers Japan Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RPHCFRohto Pharmaceutical Co., Ltd.1.56x 15.31x $576.5M $68.6M CCOJYCoca-Cola Bottlers Japan Holdings, Inc.0.66x 51.87x $1.4B -$13M
-
Which has Higher Returns RPHCF or KNBWY?
Kirin Holdings Co., Ltd. has a net margin of 11.9% compared to Rohto Pharmaceutical Co., Ltd.'s net margin of 8.88%. Rohto Pharmaceutical Co., Ltd.'s return on equity of 12.35% beat Kirin Holdings Co., Ltd.'s return on equity of 12.18%.
Company Gross Margin Earnings Per Share Invested Capital RPHCFRohto Pharmaceutical Co., Ltd.57% $0.29 $2.3B KNBWYKirin Holdings Co., Ltd.48.15% $0.36 $16.6B -
What do Analysts Say About RPHCF or KNBWY?
Rohto Pharmaceutical Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kirin Holdings Co., Ltd. has an analysts' consensus of $16.60 which suggests that it could grow by 1.9%. Given that Kirin Holdings Co., Ltd. has higher upside potential than Rohto Pharmaceutical Co., Ltd., analysts believe Kirin Holdings Co., Ltd. is more attractive than Rohto Pharmaceutical Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RPHCFRohto Pharmaceutical Co., Ltd.0 0 0 KNBWYKirin Holdings Co., Ltd.0 1 0 -
Is RPHCF or KNBWY More Risky?
Rohto Pharmaceutical Co., Ltd. has a beta of -0.205, which suggesting that the stock is 120.51% less volatile than S&P 500. In comparison Kirin Holdings Co., Ltd. has a beta of -0.060, suggesting its less volatile than the S&P 500 by 105.961%.
-
Which is a Better Dividend Stock RPHCF or KNBWY?
Rohto Pharmaceutical Co., Ltd. has a quarterly dividend of $0.14 per share corresponding to a yield of 1.9%. Kirin Holdings Co., Ltd. offers a yield of 2.84% to investors and pays a quarterly dividend of $0.24 per share. Rohto Pharmaceutical Co., Ltd. pays 26.45% of its earnings as a dividend. Kirin Holdings Co., Ltd. pays out 32.61% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RPHCF or KNBWY?
Rohto Pharmaceutical Co., Ltd. quarterly revenues are $576.5M, which are smaller than Kirin Holdings Co., Ltd. quarterly revenues of $4.4B. Rohto Pharmaceutical Co., Ltd.'s net income of $68.6M is lower than Kirin Holdings Co., Ltd.'s net income of $390.2M. Notably, Rohto Pharmaceutical Co., Ltd.'s price-to-earnings ratio is 15.31x while Kirin Holdings Co., Ltd.'s PE ratio is 13.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rohto Pharmaceutical Co., Ltd. is 1.56x versus 0.81x for Kirin Holdings Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RPHCFRohto Pharmaceutical Co., Ltd.1.56x 15.31x $576.5M $68.6M KNBWYKirin Holdings Co., Ltd.0.81x 13.38x $4.4B $390.2M
-
Which has Higher Returns RPHCF or SOOBF?
Sapporo Holdings Ltd. has a net margin of 11.9% compared to Rohto Pharmaceutical Co., Ltd.'s net margin of 3.4%. Rohto Pharmaceutical Co., Ltd.'s return on equity of 12.35% beat Sapporo Holdings Ltd.'s return on equity of 7.73%.
Company Gross Margin Earnings Per Share Invested Capital RPHCFRohto Pharmaceutical Co., Ltd.57% $0.29 $2.3B SOOBFSapporo Holdings Ltd.33.34% $0.14 $2.7B -
What do Analysts Say About RPHCF or SOOBF?
Rohto Pharmaceutical Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sapporo Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Rohto Pharmaceutical Co., Ltd. has higher upside potential than Sapporo Holdings Ltd., analysts believe Rohto Pharmaceutical Co., Ltd. is more attractive than Sapporo Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RPHCFRohto Pharmaceutical Co., Ltd.0 0 0 SOOBFSapporo Holdings Ltd.0 0 0 -
Is RPHCF or SOOBF More Risky?
Rohto Pharmaceutical Co., Ltd. has a beta of -0.205, which suggesting that the stock is 120.51% less volatile than S&P 500. In comparison Sapporo Holdings Ltd. has a beta of 0.046, suggesting its less volatile than the S&P 500 by 95.416%.
-
Which is a Better Dividend Stock RPHCF or SOOBF?
Rohto Pharmaceutical Co., Ltd. has a quarterly dividend of $0.14 per share corresponding to a yield of 1.9%. Sapporo Holdings Ltd. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.57 per share. Rohto Pharmaceutical Co., Ltd. pays 26.45% of its earnings as a dividend. Sapporo Holdings Ltd. pays out 35.98% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RPHCF or SOOBF?
Rohto Pharmaceutical Co., Ltd. quarterly revenues are $576.5M, which are smaller than Sapporo Holdings Ltd. quarterly revenues of $806.6M. Rohto Pharmaceutical Co., Ltd.'s net income of $68.6M is higher than Sapporo Holdings Ltd.'s net income of $27.4M. Notably, Rohto Pharmaceutical Co., Ltd.'s price-to-earnings ratio is 15.31x while Sapporo Holdings Ltd.'s PE ratio is 921.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rohto Pharmaceutical Co., Ltd. is 1.56x versus 4.47x for Sapporo Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RPHCFRohto Pharmaceutical Co., Ltd.1.56x 15.31x $576.5M $68.6M SOOBFSapporo Holdings Ltd.4.47x 921.02x $806.6M $27.4M
-
Which has Higher Returns RPHCF or TKHIF?
Takara Holdings, Inc. has a net margin of 11.9% compared to Rohto Pharmaceutical Co., Ltd.'s net margin of 3.73%. Rohto Pharmaceutical Co., Ltd.'s return on equity of 12.35% beat Takara Holdings, Inc.'s return on equity of 3.95%.
Company Gross Margin Earnings Per Share Invested Capital RPHCFRohto Pharmaceutical Co., Ltd.57% $0.29 $2.3B TKHIFTakara Holdings, Inc.31.05% $0.16 $2.3B -
What do Analysts Say About RPHCF or TKHIF?
Rohto Pharmaceutical Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Takara Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Rohto Pharmaceutical Co., Ltd. has higher upside potential than Takara Holdings, Inc., analysts believe Rohto Pharmaceutical Co., Ltd. is more attractive than Takara Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RPHCFRohto Pharmaceutical Co., Ltd.0 0 0 TKHIFTakara Holdings, Inc.0 0 0 -
Is RPHCF or TKHIF More Risky?
Rohto Pharmaceutical Co., Ltd. has a beta of -0.205, which suggesting that the stock is 120.51% less volatile than S&P 500. In comparison Takara Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock RPHCF or TKHIF?
Rohto Pharmaceutical Co., Ltd. has a quarterly dividend of $0.14 per share corresponding to a yield of 1.9%. Takara Holdings, Inc. offers a yield of 1.69% to investors and pays a quarterly dividend of $0.20 per share. Rohto Pharmaceutical Co., Ltd. pays 26.45% of its earnings as a dividend. Takara Holdings, Inc. pays out 37.36% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RPHCF or TKHIF?
Rohto Pharmaceutical Co., Ltd. quarterly revenues are $576.5M, which are smaller than Takara Holdings, Inc. quarterly revenues of $681.3M. Rohto Pharmaceutical Co., Ltd.'s net income of $68.6M is higher than Takara Holdings, Inc.'s net income of $25.4M. Notably, Rohto Pharmaceutical Co., Ltd.'s price-to-earnings ratio is 15.31x while Takara Holdings, Inc.'s PE ratio is 23.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rohto Pharmaceutical Co., Ltd. is 1.56x versus 0.84x for Takara Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RPHCFRohto Pharmaceutical Co., Ltd.1.56x 15.31x $576.5M $68.6M TKHIFTakara Holdings, Inc.0.84x 23.68x $681.3M $25.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
